Jefferies quarterly profit more than doubles on dealmaking, equities strength

• Advisory revenue surged 47% to a record $674.1 million, while total investment banking net revenues jumped 57.5% year-over-year to a record $1.21 billion
• Equity underwriting revenue more than tripled to $370.7 million, supported by strong IPO activity and secondary offerings as private equity firms exited portfolio companies
• Equities trading revenue rose 14% to a record $600.8 million, while the overall capital markets business grew 13.5% to $799.3 million amid persistent market volatility

Summary: Jefferies Q2 Profit More Than Doubles on Strong Dealmaking and Equities

Key Financial Results:

Jefferies Financial Group reported second-quarter profit more than doubled, driven by robust investment banking and trading activity. Investment banking net revenues surged 57.5% year-over-year to a record $1.21 billion, while advisory revenue jumped 47% to a record $674.1 million.

Market Performance:

Global M&A volumes have exceeded $2.8 trillion in 2026, led by technology, healthcare, and utility/energy sectors. Jefferies' CEO Richard Handler and President Brian Friedman expressed optimism for H2 2026, citing strong backlogs and new business bookings.

Equities Strength:

Equity underwriting revenue more than tripled to $370.7 million, supported by accelerated capital markets activity and private equity exits. Notable transactions included serving as joint global coordinator on a $6.3 billion IPO and bookrunner on several large U.S. IPOs.

Trading Revenue:

The capital markets division generated $799.3 million, up 13.5% year-over-year. Equities trading revenue climbed 14% to a record $600.8 million, while fixed income grew 12%, benefiting from market volatility as investors hedged risks.

Notable Deals:

Jefferies advised Sun Pharmaceutical on its acquisition of U.S. drugmaker Organon and Kelonia Therapeutics on a deal valued up to $7 billion.

Market Context:

The results provide early insight into Wall Street investment banking trends ahead of major U.S. banks' earnings. Jefferies' stock has rallied recently, recovering year-to-date losses after previous setbacks from exposure to British lender Market Financial Solutions and auto-parts supplier First Brands collapses. Dealmaking remains resilient despite geopolitical headwinds.